PDS Biotechnology Corporation
PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment fo…
Biotechnology
US, Florham Park [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
PDS Biotechnology Corporation can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDPDS Biotechnology Corporation can't present revenue by segment